Cardiac patients worldwide face dramatically different radiation exposures during heart disease diagnosis, raising important questions about imaging protocols and long-term cancer risk. The variation matters because cumulative radiation exposure from medical imaging has increased substantially over recent decades, with cardiac CT scans now representing a significant portion of diagnostic radiation doses.
A comprehensive analysis of radiation exposure data from coronary artery disease imaging reveals striking disparities across different countries and imaging modalities. The study examined radiation doses from CT coronary angiography, nuclear stress testing, and other cardiac imaging procedures used to diagnose heart disease. Dose variations reached 20-fold differences between highest and lowest exposure protocols, with some patients receiving radiation equivalent to hundreds of chest X-rays while others undergoing similar diagnostic workups received substantially less exposure.
This finding illuminates a critical gap in standardized imaging protocols globally. While cardiac imaging has revolutionized heart disease diagnosis and dramatically improved patient outcomes, the radiation exposure component has received less systematic attention. The variation suggests that many patients may be receiving unnecessarily high doses while achieving similar diagnostic accuracy. Given that coronary artery disease affects millions worldwide and often requires serial imaging over years, even modest reductions in per-scan radiation could significantly decrease population-level cancer risk. The data should prompt imaging centers to audit their protocols against international benchmarks and adopt dose-reduction techniques without compromising diagnostic quality. This represents an actionable opportunity to maintain diagnostic excellence while minimizing iatrogenic harm.